Endo Seeks Ruling On FTC Ability To Sue Over Past Conduct

By Eric Kroh (October 27, 2016, 5:52 PM EDT) -- Endo Pharmaceuticals Inc. has asked a Pennsylvania federal court to rule on whether the U.S. Federal Trade Commission can sue in federal court over conduct that has occurred in the past, an issue in its ongoing antitrust dispute with the agency over the drugs Opana ER and Lidoderm....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!